17,332
Total Claims
$2.9M
Drug Cost
1,255
Beneficiaries
$2,297
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+51%
Cost per patient vs peers
$2,297 vs $1,524 avg
+63%
Brand preference vs peers
22.2% vs 13.7% avg
Brand vs Generic
78% generic
Brand: 3,852 claims · $2.5M
Generic: 13,480 claims · $351K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,375 | $993K |
| Dronedarone Hcl | 373 | $369K |
| Sacubitril/Valsartan | 266 | $256K |
| Empagliflozin | 146 | $163K |
| Alirocumab | 255 | $144K |
| Rivaroxaban | 192 | $142K |
| Icosapent Ethyl | 290 | $140K |
| Evolocumab | 82 | $58K |
| Dapagliflozin Propanediol | 73 | $57K |
| Azilsartan Med/Chlorthalidone | 155 | $46K |
| Ezetimibe | 948 | $43K |
| Rosuvastatin Calcium | 1,520 | $42K |
| Azilsartan Medoxomil | 108 | $30K |
| Dabigatran Etexilate Mesylate | 61 | $29K |
| Ranolazine | 166 | $26K |
Prescribing Profile
68
Unique Drugs
$1.6M
Patient Profile
78
Avg Age
57%
Female
1.81
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data